Heartseed

Tokyo, Japan

Heartseed is a clinical- stage biotechnology firm that focuses on utilizing regenerative medicine to address heart disease.

$14.3M raised

May 2023

Series D

Top Investors

SBI InvestmentSMBC Venture CapitalNissay CapitalSumitomo Mitsui Trust InvestmentKeio Innovation Initiative

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Heartseed raised?

Heartseed has raised $14.3M in total funding. The most recent round was Series D. The last funding was announced in May 2023.

Who are Heartseed's investors?

Heartseed's investors include SBI Investment, SMBC Venture Capital, Nissay Capital, Sumitomo Mitsui Trust Investment, Keio Innovation Initiative.

Where is Heartseed headquartered?

Heartseed is headquartered in Tokyo, Japan.

What does Heartseed do?

Heartseed is a clinical- stage biotechnology firm that focuses on utilizing regenerative medicine to address heart disease.

What stage is Heartseed at?

Heartseed is at the Series D stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 25, 2023.

MLA

"Heartseed — Funding & Investors." VCBacked, May 25, 2023, https://www.vcbacked.co/company/heartseed. Accessed June 4, 2026.

APA

VCBacked. (2023). Heartseed — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/heartseed

Wikipedia (cite web)

{{cite web |title=Heartseed — Funding & Investors |url=https://www.vcbacked.co/company/heartseed |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 25, 2023.